BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 542927)

  • 41. Thromboplastin calibration. Experience of the Dutch reference laboratory for anticoagulant control.
    Loeliger EA; van der Hoeff-van Halem R; van Halem-Visser LP
    Thromb Haemost; 1978 Oct; 40(2):272-87. PubMed ID: 734632
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Diagnostic kits in parasitology: which controls?].
    Rossi P
    Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thromboplastin standardisation: calibrated lyophilised plasmas and coagulometer-specific international sensitivity indices.
    Dunford SR
    Br J Biomed Sci; 1998 Dec; 55(4):276-80. PubMed ID: 10436545
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A simplified procedure for thromboplastin calibration--the usefulness of lyophilized plasmas assessed in a collaborative study.
    Tripodi A; Chantarangkul V; Manotti C; Poggi M; Braga M; Akkawat B; Bucciarelli P; Mannucci PM
    Thromb Haemost; 1996 Feb; 75(2):309-12. PubMed ID: 8815582
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of international normalized ratios by a controlled field survey with 4 different thromboplastin reagents.
    Kazama M; Suzuki S; Abe T; Tahara C; Shimazu C; Akiyama Y; Higashi K; Ishiguro I; Kimura T; Motoi S
    Thromb Haemost; 1990 Dec; 64(4):535-41. PubMed ID: 2084938
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reference materials and reference measurement systems in laboratory medicine. Prothrombin time standardization: the problem of the control plasma.
    D'Angelo A
    Eur J Clin Chem Clin Biochem; 1995 Dec; 33(12):1019-22. PubMed ID: 8845419
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Validity of the INR system for patients with liver impairment.
    Denson KW; Reed SV; Haddon ME
    Thromb Haemost; 1995 Jan; 73(1):162. PubMed ID: 7740488
    [No Abstract]   [Full Text] [Related]  

  • 48. Long-term stability of international reference preparations for thromboplastins.
    van den Besselaar AM; Hermans J; Beeser H; Loeliger EA
    Br J Haematol; 1988 Mar; 68(3):321-8. PubMed ID: 3355790
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis A immunoglobulin: an international collaborative study to establish the second international standard.
    Ferguson M; Sands D; Lelie N
    Biologicals; 2000 Dec; 28(4):233-40. PubMed ID: 11237359
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Lyophilized plasmas for the control of thromboplastin time values and calibration of thromboplastins].
    Sikorová J; Vorlová Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(3):423-8. PubMed ID: 2444517
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of the choice of WHO International Reference Preparation for thromboplastin on International Normalised Ratios.
    Poller L; Taberner DA; Thomson JM; Morris J; Mibashan RS; Shinton NK
    J Clin Pathol; 1993 Jan; 46(1):64-6. PubMed ID: 8432892
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of a lyophilized reference plasma to compare coagulation test procedures: Normotest, Simplastin-A and Thrombotest.
    Kahan J; Norén I
    Thromb Diath Haemorrh; 1975 Nov; 34(2):426-44. PubMed ID: 1198406
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Status of present and candidate international reference preparations (IRP) of thromboplastin for the prothrombin time. A report of the Subcommittee for Control of Anticoagulation.
    van den Besselaar AM; Lewis SM; Mannucci PM; Poller L
    Thromb Haemost; 1993 Jan; 69(1):85. PubMed ID: 8446942
    [No Abstract]   [Full Text] [Related]  

  • 54. [Evaluation of the quality of prothrombin time technique in the Basque Country].
    Vacas M; Lafuente PJ; Aguirrebeitia MJ; Iriarte JA
    Sangre (Barc); 1998 Feb; 43(1):41-5. PubMed ID: 9577180
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thromboplastin and oral anticoagulant control.
    Lewis SM
    Br J Haematol; 1987 May; 66(1):1-4. PubMed ID: 3593643
    [No Abstract]   [Full Text] [Related]  

  • 56. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
    Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A
    Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control.
    Loeliger EA; van den Besselaar AM; Lewis SM
    Thromb Haemost; 1985 Feb; 53(1):148-54. PubMed ID: 3992514
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Report of a collaborative study to establish the international standard for parvovirus B19 serum IgG.
    Ferguson M; Walker D; Cohen B
    Biologicals; 1997 Sep; 25(3):283-8. PubMed ID: 9324996
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A simple nomogram for the derivation of international normalised ratios for the standardisation of prothrombin times.
    Poller L
    Thromb Haemost; 1988 Aug; 60(1):18-20. PubMed ID: 3187944
    [TBL] [Abstract][Full Text] [Related]  

  • 60. International sensitivity index calibration of the near-patient testing prothrombin time monitor, ProTime.
    Tripodi A; Chantarangkul V; Bressi C; Mannucci PM
    Am J Clin Pathol; 2003 Feb; 119(2):241-5. PubMed ID: 12579994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.